Article

Cancer Survivorship Superstitions: Can a Delayed Mammogram Be Catastrophic?

A routine can feel so comfortable that change is hard. So, when my annual mammogram and cancer checkup was delayed, I tried hard not to sweat the small stuff.

I thought cancer taught me not to sweat the small stuff. I guess even I have my limits and thus room for improvement.

There I was, checking in for the annual mammogram of my remaining breast, which gets extra attention because of my cancer history. This mammogram comes annually the same day I visit the lab in the cancer center for a blood draw to prepare for a visit with my oncologist.

In between appointments, I stop at a gift shop in the hospital that connects the cancer center and the women’s center because it is so cheerful.

Perhaps, despite my visit to the gift shop, I was in a bad mood already upon entrance to the women’s center because when I looked a question asking for family history of breast cancer, I wrote “too many to count.” 

Each year, the same facility that first alerted me to my breast cancer also asks me about family history and if I have ever had breast cancer and cancer treatment. I answer those questions.

This year, I rebelled at the question regarding family history, which is not like me.

Fortunately, that sheet of paper got tossed when I learned the mammogram had to be cancelled as it had been only four weeks since my third COVID-19 booster. This news is what sent me over the edge. I was told I would need to wait two more weeks because sometimes a mammogram will pick up swollen lymph nodes related to the vaccine. Or a month, as they were booked up, the clerk advised.

Losing it can be subtle. You do not have to pick up a clipboard and throw it across the room or say a harsh word to an innocent clerk whose job is simply to welcome you to your mammogram. In this case, I quibbled with the clerk, who had no control over the policy, as I explained the importance of regular mammograms for breast cancer survivors.

This delay, I exclaimed, would have a ripple effect on my oncology checkup. Fighting back tears, I thought, “And maybe my life!”

So accustomed to my October ritual, I entertained the irrational thought that any delay would guarantee more breast cancer. Thankfully, the clerk knew how to deal patiently with high emotions. I caught my breath and left.

Before leaving the building, I called the scheduling office, where another clerk scheduled me not so far out in the future but precisely one day after the wait was over. This clerk sounded like a mental health counselor, kind and understanding about my emotions regarding the change in my routine. She found a cancellation, which I later wondered was really a way to squeeze me in because the day I went back I waited, without complaining, an hour for the mammogram. The cancer center, too, set up a new appointment a week after the new mammogram.

At the rescheduled visit to the women’s center, I began by apologizing to the clerk who had helped me two weeks before. She smiled and reassured me that no offense had been taken.

Then, taking a deep breath, I used a favorite fountain pen to fill out the annoying form, a trick I thought would distract me from the repetitive questions. Neatly identifying closest relatives who had breast cancer, including one new entry, I signed the paper with a flourish. When I handed in the form, I thanked the clerk one more time for her patience.

The morale of this tale is that change is hard when we get in a rut that feels like a life-saving ritual. There was no need for me to feel superstitious about a brief delay. Now I am thankful for the annual oncology checkup and good to go for another year. Most of all, I have learned another good lesson about trying harder not to sweat the small stuff.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Dr. Debu Tripathy is a professor and chairman of the Department of Breast Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, in Houston, and the editor-in-chief of CURE®.
Dr. John Oertle discusses the key benefits to come from patients with cancer connecting with support networks, advocacy groups and resources.
Dr. Gabriel A. Brooks discussed the recent FDA product labeling update for Xeloda and 5-FU.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine in the Department of Medicine at Beth Israel Deaconess Medical Center in Boston.
Photo credit: Max Mumby/Indigo via Getty Images
Dr. Maxwell Lloyd, a Clinical Fellow in Medicine, in the Department of Medicine, at Beth Israel Deaconess Medical Center in Boston.
Dr. Aditya Bardia is a professor in the Department of Medicine, Division of Hematology/Oncology, director of Translational Research Integration, and a member Signal Transduction and Therapeutics, at University of California, Los Angeles (UCLA) Health Jonsson Comprehensive Cancer Center.
Image of a woman with light shoulder-length hair, wearing rectangular glasses.